Landos Biopharma

+$0.26 (+1.77%) Today
$0.00 (0.00%) As of 8:14 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LABP and other ETFs, options, and stocks.

About LABP

Landos Biopharma, Inc. engages in the development and commercialization of novel therapeutics for autoimmune diseases. The firm offers BT-11, a novel, oral, gut-restricted therapeutic candidate for the treatment of ulcerative colitis and Crohn’s disease that targets the LANCL2 pathway.

CEO
Josep Bassaganya-Riera
Employees
33
Headquarters
Blacksburg, Virginia
Founded
2017

LABP Key Statistics

Market Cap
598.55M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
48.44K
High Today
$15.00
Low Today
$14.76
Open Price
$15.00
Volume
118.11K
52 Week High
$16.99
52 Week Low
$8.82

LABP Earnings

-$0.38
-$0.21
-$0.05
$0.12
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure